Advisor Group Holdings, Inc. Ligand Pharmaceuticals Inc Transaction History

Advisor Group Holdings, Inc.

  • $52.6 Billion
  • Q2 2025

A detailed history of Advisor Group Holdings, Inc. transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 5,860 shares of LGND stock, worth $1.19 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,860
Previous 4,486 30.63%
Holding current value
$1.19 Million
Previous $509,000 30.84%
% of portfolio
0.0%
Previous 0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Sep 04, 2025
BUY
$96.67 - $118.22 $132,824 - $162,434
1,374 Added 30.63%
5,860 $666,000
Q2 2025

Aug 13, 2025
BUY
$96.67 - $118.22 $224,371 - $274,388
2,321 Added 107.21%
4,486 $509,000
Q1 2025

May 12, 2025
SELL
$105.14 - $122.23 $41,109 - $47,791
-391 Reduced 15.3%
2,165 $227,000
Q4 2024

Jun 06, 2025
SELL
$99.95 - $129.9 $12,493 - $16,237
-125 Reduced 5.77%
2,040 $218,000
Q4 2024

Feb 07, 2025
SELL
$99.95 - $129.9 $126,936 - $164,973
-1,270 Reduced 33.19%
2,556 $273,000
Q3 2024

Nov 13, 2024
BUY
$82.7 - $110.11 $38,620 - $51,421
467 Added 13.9%
3,826 $383,000
Q2 2024

Aug 13, 2024
BUY
$68.53 - $87.91 $186,538 - $239,291
2,722 Added 427.32%
3,359 $283,000
Q1 2024

May 10, 2024
SELL
$68.64 - $89.2 $45,439 - $59,050
-662 Reduced 50.96%
637 $46,000
Q4 2023

Feb 12, 2024
SELL
$49.57 - $72.63 $12,095 - $17,721
-244 Reduced 15.81%
1,299 $92,000
Q3 2023

Nov 13, 2023
BUY
$58.86 - $72.67 $11,242 - $13,879
191 Added 14.13%
1,543 $92,000
Q2 2023

Aug 10, 2023
BUY
$69.53 - $79.33 $903 - $1,031
13 Added 0.97%
1,352 $97,000
Q1 2023

May 12, 2023
SELL
$65.67 - $77.08 $1,970 - $2,312
-30 Reduced 2.19%
1,339 $98,000
Q4 2022

Feb 10, 2023
SELL
$61.72 - $96.74 $5,061 - $7,932
-82 Reduced 5.65%
1,369 $91,000
Q3 2022

Nov 14, 2022
BUY
$0.01 - $107.56 $0 - $3,226
30 Added 2.11%
1,451 $125,000
Q2 2022

Aug 10, 2022
BUY
$74.52 - $117.06 $5,961 - $9,364
80 Added 5.97%
1,421 $127,000
Q1 2022

May 04, 2022
BUY
$94.99 - $151.56 $7,409 - $11,821
78 Added 6.18%
1,341 $151,000
Q3 2021

Nov 05, 2021
SELL
$102.33 - $144.73 $7,879 - $11,144
-77 Reduced 5.75%
1,263 $175,000
Q2 2021

Aug 02, 2021
SELL
$113.03 - $155.64 $51,541 - $70,971
-456 Reduced 25.39%
1,340 $175,000
Q1 2021

May 13, 2021
SELL
$99.52 - $215.83 $56,228 - $121,943
-565 Reduced 23.93%
1,796 $273,000
Q4 2020

Feb 10, 2021
SELL
$80.55 - $106.05 $86,269 - $113,579
-1,071 Reduced 31.21%
2,361 $236,000
Q3 2020

Nov 12, 2020
SELL
$89.56 - $126.72 $18,449 - $26,104
-206 Reduced 5.66%
3,432 $332,000
Q2 2020

Aug 14, 2020
BUY
$68.28 - $123.65 $5,257 - $9,521
77 Added 2.16%
3,638 $407,000
Q1 2020

May 18, 2020
BUY
$63.37 - $107.88 $225,660 - $384,160
3,561 New
3,561 $257,000

Others Institutions Holding LGND

# of Institutions
306
Shares Held
20M
Call Options Held
9K
Put Options Held
0
View Full List

About LIGAND PHARMACEUTICALS INC

LGND Quotes by TradingView
  • Ticker LGND
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,882,800
  • Market Cap $3.42B
  • Description
  • Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...
More about LGND
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email